Prenetics Global - 28 Year Dividend History | PRE
Historical dividend payout and yield for Prenetics Global (PRE) since 1996. The current TTM dividend payout for Prenetics Global (PRE) as of December 11, 2024 is $0.00. The current dividend yield for Prenetics Global as of December 11, 2024 is 0.00%.
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.047B |
$0.022B |
Prenetics, a leading genomics-driven health sciences company, is revolutionizing prevention, early detection, and treatment. Their prevention arm, CircleDNA, uses whole exome sequencing to offer the world's most comprehensive consumer DNA test. Insighta, their joint venture with renowned scientist Prof. Dennis Lo, underscores their unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Lastly, ACT Genomics, their treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances their global impact on health, truly embodying their commitment to 'enhancing life through science'.
|
Stock Name |
Country |
Market Cap |
PE Ratio |